Spearman correlation between the clinical outcome measures and the generalized TOS scores of multicomponent combinations.

1All the clinical outcome measures were recorded based on the Response Evaluation Criteria in Solid Tumors (RECIST)[35]2Spearman's rank correlation coefficient3p-values for Spearman's rank correlation coefficient4Overall Response5Overall Survival Rate6Confirmed Clinical Benefit7Median Progression Free SurvivalSpearman correlation between the clinical outcome measures and the generalized TOS scores of multicomponent combinations.

1. 所有临床结局指标均依据实体瘤疗效评价标准（Response Evaluation Criteria in Solid Tumors, RECIST）[35]进行记录。
2. 斯皮尔曼等级相关系数（Spearman's rank correlation coefficient）
3. 斯皮尔曼等级相关系数的p值
4. 总体应答率（Overall Response）
5. 总生存率（Overall Survival Rate）
6. 确认的临床获益（Confirmed Clinical Benefit）
7. 中位无进展生存期（Median Progression Free Survival）
临床结局指标与多组分组合的广义TOS评分之间的斯皮尔曼相关性。